Impact of newly diagnosed abnormal glucose regulation on long-term prognosis in low risk patients with ST-elevation myocardial infarction: A follow-up study

BMC Endocrine Disorders

Volumn 11, Issue , 2011, Pages

  Knudsen, Eva C ^a   Seljeflot, Ingebjørg ^a,b   Abdelnoor, Michael ^a   Eritsland, Jan ^a   Mangschau, Arild ^a   Müller, Carl ^a   Arnesen, Harald ^a,b   Andersen, Geir T ^a  

^a ULLEVÅL UNIVERSITY HOSPITAL   (Norway)

^b UNIVERSITY OF OSLO   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE;

ABNORMAL GLUCOSE REGULATION; ACUTE HEART INFARCTION; ADULT; ARTICLE; DISORDERS OF CARBOHYDRATE METABOLISM; FEMALE; FOLLOW UP; GLUCOSE BLOOD LEVEL; HEART MUSCLE ISCHEMIA; HEART REINFARCTION; HOSPITAL ADMISSION; HUMAN; IMPAIRED GLUCOSE TOLERANCE; MAJOR CLINICAL STUDY; MALE; MORTALITY; NON INSULIN DEPENDENT DIABETES MELLITUS; ORAL GLUCOSE TOLERANCE TEST; PERCUTANEOUS CORONARY INTERVENTION; PROGNOSIS; RECURRENT DISEASE; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; STROKE;

EID: 79960869892     PISSN: None     EISSN: 14726823     Source Type: Journal    
DOI: 10.1186/1472-6823-11-14     Document Type: Article

References (31)

1. Demir I, Yilmaz H, Basarici I, Sancaktar O, Deger N. Primary percutaneous coronary interventions in acute myocardial infarction in diabetic versus non-diabetic patients. In-hospital and long-term results. Kardiol Pol 2003, 58:182-189.
2. Aguilar D, Solomon SD, Kober L, Rouleau JL, Skali H, McMurray JJ, Francis GS, Henis M, O'Connor CM, Diaz R, Belenkov YN, Varshavsky S, Leimberger JD, Velazquez EJ, Califf RM, Pfeffer MA. Newly diagnosed and previously known diabetes mellitus and 1-year outcomes of acute myocardial infarction: the VALsartan In Acute myocardial iNfarcTion (VALIANT) trial. Circulation 2004, 110:1572-1578. 10.1161/01.CIR.0000142047.28024.F2, 15364810.
3. Abbud ZA, Shindler DM, Wilson AC, Kostis JB. Effect of diabetes mellitus on short- and long-term mortality rates of patients with acute myocardial infarction: a statewide study. Myocardial Infarction Data Acquisition System Study Group. Am Heart J 1995, 130:51-58. 10.1016/0002-8703(95)90235-X, 7611123.
4. De Luca G, Sauro R, Varricchio A, Capasso M, Lanzillo T, Manganelli F, Mariello C, Siano F, Carbone G, Pagliuca MR, Rosato G, Di LE. Impact of diabetes on long-term outcome in STEMI patients undergoing primary angioplasty with glycoprotein IIb-IIIa inhibitors and BMS or DES. J Thromb Thrombolysis 2010, 30:133-141. 10.1007/s11239-009-0420-5, 19921102.
5. Hsu LF, Mak KH, Lau KW, Sim LL, Chan C, Koh TH, Chuah SC, Kam R, Ding ZP, Teo WS, Lim YL. Clinical outcomes of patients with diabetes mellitus and acute myocardial infarction treated with primary angioplasty or fibrinolysis. Heart 2002, 88:260-265. 10.1136/heart.88.3.260, 1767339, 12181218.
6. Bartnik M, Ryden L, Ferrari R, Malmberg K, Pyorala K, Simoons M, Standl E, Soler-Soler J, Ohrvik J. The prevalence of abnormal glucose regulation in patients with coronary artery disease across Europe. The Euro Heart Survey on diabetes and the heart. Eur Heart J 2004, 25:1880-1890. 10.1016/j.ehj.2004.07.027, 15522466.
7. Hu DY, Pan CY, Yu JM. The relationship between coronary artery disease and abnormal glucose regulation in China: the China Heart Survey. Eur Heart J 2006, 27:2573-2579. 10.1093/eurheartj/ehl207, 16984927.
8. Bartnik M, Malmberg K, Norhammar A, Tenerz A, Ohrvik J, Ryden L. Newly detected abnormal glucose tolerance: an important predictor of long-term outcome after myocardial infarction. Eur Heart J 2004, 25:1990-1997. 10.1016/j.ehj.2004.09.021, 15541834.
9. Ryden L, Standl E, Bartnik M, Van den BG, Betteridge J, de Boer MJ, Cosentino F, Jonsson B, Laakso M, Malmberg K, Priori S, Ostergren J, Tuomilehto J, Thrainsdottir I, Vanhorebeek I, Stramba-Badiale M, Lindgren P, Qiao Q, Priori SG, Blanc JJ, Budaj A, Camm J, Dean V, Deckers J, Dickstein K, Lekakis J, McGregor K, Metra M, Morais J, Osterspey A, et al. Guidelines on diabetes, pre-diabetes, and cardiovascular diseases: executive summary. The Task Force on Diabetes and Cardiovascular Diseases of the European Society of Cardiology (ESC) and of the European Association for the Study of Diabetes (EASD). Eur Heart J 2007, 28:88-136.
10. Knudsen EC, Seljeflot I, Abdelnoor M, Eritsland J, Mangschau A, Arnesen H, Andersen GO. Abnormal glucose regulation in patients with acute ST- elevation myocardial infarction-a cohort study on 224 patients. Cardiovasc Diabetol 2009, 8:6. 10.1186/1475-2840-8-6, 2646717, 19183453.
11. Dickstein K, Cohen-Solal A, Filippatos G, McMurray JJ, Ponikowski P, Poole-Wilson PA, Stromberg A, van Veldhuisen DJ, Atar D, Hoes AW, Keren A, Mebazaa A, Nieminen M, Priori SG, Swedberg K. ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the diagnosis and treatment of acute and chronic heart failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM). Eur J Heart Fail 2008, 10:933-989. 10.1016/j.ejheart.2008.08.005, 18826876.
12. World Health Organization Department of Noncommunicable Disease Surveillance G. Definition, Diagnosis and Classification of Diabetes Mellitus and its complication. Report of a WHO Consultation 1999, 1-59., http://www.staff.ncl.ac.uk/philip.home/who_dmg.pdf
13. World Health Organization, International Diabetes Federation. Definition and diagnosis of diabetes mellitus and intermediate hyperglycaemia. Report of a WHO/IDF Consultation 2005, 1-46., http://whqlibdoc.who.int/publications/2006/9241594934_eng.pdf
14. Thygesen K, Alpert JS, White HD. Universal definition of myocardial infarction. Eur Heart J 2007, 28:2525-2538.
15. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985, 28:412-419. 10.1007/BF00280883, 3899825.
16. Gibbons RJ, Miller TD, Christian TF. Infarct size measured by single photon emission computed tomographic imaging with (99 m)Tc-sestamibi: A measure of the efficacy of therapy in acute myocardial infarction. Circulation 2000, 101:101-108.
17. Kleinbaum DG, Kupper LL, Morgenstern H. Epidemiologic research. Principles and quantitative methods 1982, New York: Van Nostrand Reinhold Company Inc.
18. von Elm E, Altman DG, Egger M, Pocock SJ, Gotzsche PC, Vandenbroucke JP. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Lancet 2007, 370:1453-1457. 10.1016/S0140-6736(07)61602-X, 18064739.
19. Lavi S, Kapeliovich M, Gruberg L, Roguin A, Boulos M, Grenadier E, Amikam S, Markiewicz W, Beyar R, Hammerman H. Hyperglycemia during acute myocardial infarction in patients who are treated by primary percutaneous coronary intervention: impact on long-term prognosis. Int J Cardiol 2008, 123:117-122. 10.1016/j.ijcard.2006.11.222, 17367882.
20. Norhammar AM, Ryden L, Malmberg K. Admission plasma glucose. Independent risk factor for long-term prognosis after myocardial infarction even in nondiabetic patients. Diabetes Care 1999, 22:1827-1831. 10.2337/diacare.22.11.1827, 10546015.
21. Aronson D, Hammerman H, Suleiman M, Markiewicz W. Usefulness of changes in fasting glucose during hospitalization to predict long-term mortality in patients with acute myocardial infarction. Am J Cardiol 2009, 104:1013-1017. 10.1016/j.amjcard.2009.05.053, 19801016.
22. Straumann E, Kurz DJ, Muntwyler J, Stettler I, Furrer M, Naegeli B, Frielingsdorf J, Schuiki E, Mury R, Bertel O, Spinas GA. Admission glucose concentrations independently predict early and late mortality in patients with acute myocardial infarction treated by primary or rescue percutaneous coronary intervention. Am Heart J 2005, 150:1000-1006. 10.1016/j.ahj.2005.01.033, 16290985.
23. Gasior M, Pres D, Stasik-Pres G, Lech P, Gierlotka M, Hawranek M, Wilczek K, Szygula-Jurkiewicz B, Lekston A, Kalarus Z, Strojek K, Gumprecht J, Polonski L. Effect of blood glucose levels on prognosis in acute myocardial infarction in patients with and without diabetes, undergoing percutaneous coronary intervention. Cardiol J 2008, 15:422-430.
24. Lazzeri C, Valente S, Chiostri M, Picariello C, Gensini GF. In-hospital peak glycemia and prognosis in STEMI patients without earlier known diabetes. Eur J Cardiovasc Prev Rehabil 2010, 17:419-423. 10.1097/HJR.0b013e328335f26f, 20517158.
25. Tenerz A, Norhammar A, Silveira A, Hamsten A, Nilsson G, Ryden L, Malmberg K. Diabetes, insulin resistance, and the metabolic syndrome in patients with acute myocardial infarction without previously known diabetes. Diabetes Care 2003, 26:2770-2776. 10.2337/diacare.26.10.2770, 14514578.
26. Norhammar A, Tenerz A, Nilsson G, Hamsten A, Efendic S, Ryden L, Malmberg K. Glucose metabolism in patients with acute myocardial infarction and no previous diagnosis of diabetes mellitus: a prospective study. Lancet 2002, 359:2140-2144. 10.1016/S0140-6736(02)09089-X, 12090978.
27. Lenzen M, Ryden L, Ohrvik J, Bartnik M, Malmberg K, Scholte Op RW, Simoons ML. Diabetes known or newly detected, but not impaired glucose regulation, has a negative influence on 1-year outcome in patients with coronary artery disease: a report from the Euro Heart Survey on diabetes and the heart. Eur Heart J 2006, 27:2969-2974. 10.1093/eurheartj/ehl363, 17090612.
28. Lazzeri C, Valente S, Chiostri M, Picariello C, Gensini GF. Acute glucose dysmetabolism in the elderly with ST elevation myocardial infarction submitted to mechanical revascularization. Int J Cardiol 2011,
29. Anselmino M, Malmberg K, Ohrvik J, Ryden L. Evidence-based medication and revascularization: powerful tools in the management of patients with diabetes and coronary artery disease: a report from the Euro Heart Survey on diabetes and the heart. Eur J Cardiovasc Prev Rehabil 2008, 15:216-223. 10.1097/HJR.0b013e3282f335d0, 18391651.
30. Malmberg K, Ryden L, Wedel H, Birkeland K, Bootsma A, Dickstein K, Efendic S, Fisher M, Hamsten A, Herlitz J, Hildebrandt P, MacLeod K, Laakso M, Torp-Pedersen C, Waldenstrom A. Intense metabolic control by means of insulin in patients with diabetes mellitus and acute myocardial infarction (DIGAMI 2): effects on mortality and morbidity. Eur Heart J 2005, 26:650-661. 10.1093/eurheartj/ehi199, 15728645.
31. Mehta SR, Yusuf S, Diaz R, Zhu J, Pais P, Xavier D, Paolasso E, Ahmed R, Xie C, Kazmi K, Tai J, Orlandini A, Pogue J, Liu L. Effect of glucose-insulin-potassium infusion on mortality in patients with acute ST-segment elevation myocardial infarction: the CREATE-ECLA randomized controlled trial. JAMA 2005, 293:437-446.